Edition:
United States

Achillion Pharmaceuticals Inc (ACHN.O)

ACHN.O on Nasdaq

3.42USD
27 Apr 2017
Change (% chg)

$-0.08 (-2.29%)
Prev Close
$3.50
Open
$3.53
Day's High
$3.55
Day's Low
$3.42
Volume
785,054
Avg. Vol
1,452,406
52-wk High
$10.06
52-wk Low
$3.15

ACHN.O

Chart for ACHN.O

About

Achillion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is engaged in the discovery and development of small molecule drug therapies for infectious diseases and immune system disorders. The Company is focused on its complement inhibitor platform, directed at advancing small molecule compounds that have the... (more)

Overall

Beta: 1.55
Market Cap(Mil.): $478.53
Shares Outstanding(Mil.): 136.72
Dividend: --
Yield (%): --

Financials

  ACHN.O Industry Sector
P/E (TTM): -- 58.41 30.30
EPS (TTM): -0.45 -- --
ROI: -14.52 0.45 13.24
ROE: -14.53 6.31 14.40

BRIEF-Achillion announces initiation of patient dosing in phase 2 study of ACH-4471

* Achillion announces initiation of patient dosing in phase 2 study of ACH-4471 for paroxysmal nocturnal hemoglobinuria

Apr 06 2017

BRIEF-Achillion Pharmaceuticals to support a natural history study of C3 glomerulopathy

* Achillion Pharmaceuticals to support a natural history study of C3 glomerulopathy, a rare renal disorder, conducted by experts at Imperial College London Source text for Eikon: Further company coverage:

Feb 28 2017

BRIEF-Achillion Pharmaceuticals Inc says files for mixed shelf of upto $250 million

* Achillion Pharmaceuticals Inc says files for mixed shelf of upto $250 million - SEC filing Source text for Eikon: (http://bit.ly/2l58Pa8) Further company coverage:

Feb 23 2017

BRIEF-Achillion Pharmaceuticals Q4 revenue $15 million

* Achillion reports 2016 fourth quarter and year-end financial results

Feb 23 2017

BRIEF-Achillion Q3 loss per share $0.15

* Achillion Pharmaceuticals Inc says recognized in q3 of 2015 revenue of $33.8 million under janssen agreement

Nov 03 2016

More From Around the Web

Competitors

  Price Chg
Pfizer Inc. (PFE.N) $33.86 +0.01
Johnson & Johnson (JNJ.N) $123.74 +0.23
Novartis AG (NOVN.S) CHF76.90 +0.75
Merck & Co., Inc. (MRK.N) $62.58 -0.12
Roche Holding Ltd. (ROG.S) CHF260.30 +2.50
Roche Holding Ltd. (RO.S) CHF261.50 +3.00
Abbott Laboratories (ABT.N) $43.65 -0.15
AstraZeneca plc (AZN.L) 4,698.00 +11.50
GlaxoSmithKline plc (GSK.L) 1,558.50 -7.50
Bristol-Myers Squibb Co (BMY.N) $55.67 +1.90

Earnings vs. Estimates